RAREfest brings life sciences to Guildhall
Heartwarming, uplifting and informative, the world’s first-ever festival on rare diseases drew huge crowds to the Guildhall at the weekend (November 30/December 1).
The event opened on Friday evening with introductions by Alastair Kent, OBE, the former director of Genetic Alliance UK.
“A few years ago it would not have been possible to have filled a hall like this,” he told the 200 attendees. “There are now 8,000 rare diseases affecting 3.5million people in the UK at some point in their lives. But it’s not just about a medical condition, we’re going to see some real stars to make us aware of the way that society can be changed for the better.”
First up was Abbi Brown, a CRDN founder and Cambridge graduate born with osteogenesis imperfecta (OI), a genetic disorder which means her bones are extremely fragile and prone to breaks or fractures. Abbi related her experiences as a cox while a student, and described how easily her bones break. She did this with a sense of humour which has seen her perform at the Edinburgh Fringe.
Abbi was followed by a troupe of dancers, the children’s dance group Unique Feet. I wasn’t the only one to have a tear in my eye while watching their performance, they were so brave and powerful. In the interval I spoke with one of the dancers, Chloe King, aged 13, from Bar Hill, who was there with mum Jackie and dad Paul. Chloe has dyskerotosis congenita - a weakened immune system that doesn’t fight off infection. Like every rare disease sufferer here they and/or their families are very clued up about the mechanics of the disorder. Jackie explains that Chloe has a dysfunction of the telomere.
“The telomere is at the end of a chromosome and it’s like a shoelace, and the lace frays at the end and that’s the cells misbehaving.”
“My bone marrow gets low,” adds Chloe. “Half way through the day I get exhausted.”
Treatment options are increasing. Research is aimed at getting the body to restore the bone marrow more efficiently. The Kings are a lovely family and, like so many of those present, trying to imagine what they must have been through makes me tear up again.
Next on stage are Adam Pearson and Dagmar Bennett. Adam is a campaigner who suffers from neurofibromatosis, which causes excess skin to grow, especially but not exclusively facially. “It just happens,” he says of his condition. Dagmar is an artist who produced a sculpture of Adam as part of a course at the Centre for Appearance Research in Bristol: the work took seven months.
“I wanted to show Adam’s character,” she told the audience. “I was trying to get into the psychology, to use art to break down barriers.”
“We are bombarded every day by media images of how we should look,” noted Adam. “For people with disfigurement it can be absolutely paralysing.”
He has devoted his life to changing opinions. “As a campaigner I believe everything you do should serve a greater purpose.”
Adam and Dagmar’s powerful collective voice was followed James Risdon, who plays recorder. James' rare eye condition, Leber’s Congenital Amaurosis, means he learns his repertoire from Braille. His music, with piano accompaniment, is accomplished and mesmerising, and is followed by another powerful voice, Michael McGrath. Michael is the first person to have been to both the North and South Poles despite having limb girdle muscular dystrophy (MD). Just as his body started shutting down on him, he raised his game and did things people said were impossible. His charity, Muscle Help Foundation, highlights what fighters many people with rare diseases are: Michael's was an uplifting, life-affirming talk on an emotional and enchanting evening.
Saturday’s events were no less astounding, with talks about the incredible progress the medical sector is making to cure many rare diseases as new genomic data is integrated into medical practice. The main hall became a forum for stalls run by companies including Horizon Discovery, Abcam, No Isolation, The Wellcome MRC Cambridge Stem Cell Institute, LifeArc (the new name for Medical Research Council Technology), CRDN, Heterogeneous, Pfizer and Microsoft.
I bumped into a BBC4 camerawoman, Ila Mehrotra, who’s part of a crew covering the festival, which had 600 visitors during the day.
“I’m working on a film about the history of genetics and particularly the context of eugenics,” said Ila.
Ila says eugenics started in the early 20th century before being highjacked by the Nazis in the 1930s.
“Eugenics, historically, was gene selection," she said. "It was very much the preservation of the ‘most fit race’ which in the 1930s when it came out was the white race and scientists washed their hands of it completely.
“We’re looking at the positive aspects of how it can help people. We have Adam (Pearson) as a presenter and a black woman so we’re looking at it as a humane programme – it’s only just begun.”
Visitors are offered headphones to hear the talks while walking round the stalls. There’s a film festival which is packed out. The speakers I hear are wonderful, and the questions are very well informed. So who else is listening?
“Lots of people we’ve spoken to today are passers-by,” says Harriet Gridley, head of business development UK at No Isolation, a Norwegian firm which produces a robot, AV1, which can help children learn at home if they condition prevents them going to school. “They’re out doing their Christmas shopping. That’s wonderful because it means the topic is broadening out to the wider community.”
“It’s a mix of professionals and members of the public,” said architect Vaila Morrison, whose daughter’s rare disease is making her reconsider the built environment.
“It’s been brilliant, what a brilliant day,” said Abcam co-founder and deputy chairman Jonathan Milner later in the afternoon. Dr Milner was also at Dr Anna Middleton’s talk. Dr Middleton isfounder and Head of Society and Ethics Research at Connecting Science in the Wellcome Genome Campus. Her work has addressed the issue of how genomic data should be made available. So far the sector seems to consider it acceptable that a person's genomic data should be made available to all research organisations, but the recent work by a Chinese scientist - gene-diting an embroy which was then born - has highlighted a difference of views. People are expected to be donating their genomic data to science but the industry is seekign ways to charge for the use they make of it. Intriguingly, differentnations see this issue in different lights. Dr Middleton's study showed that Russians and Portuguese are happy for all genetic information to be shared for free: Britons, Australians and Germans, on the other hand, are less keen. The public is entitled to ask what would the information be used for? We’ve all seen what happened with Facebook, where an apparently innocuous sharing platform turned out to have a very dark underbelly. The issue of trust is crucial in what happens next, but one thing’s for sure: those attending this ground-breaking festival have found their tribe, and the support networks they need are now being built – all thanks to CRDN.
Dr Sarah Leiter, a junior doctor Addenbrooke's Hospital, lives with a rare condition - albinism - herself. She said: “RareFest proved a unique opportunity to educate the general public about rare disease but also to bring together local stakeholders. We hope that through this work we will improve the lives of those with rare disease.”
Jo Balfour, RAREfest and CRDN events manager, said: “Our RAREfest launch event, with performances by those living with rare conditions, was widely applauded by those attending for its diversity, inclusion and for breaking down barriers. We’ve be delighted by the positive feedback on our main exhibition which exhibitors, speakers and attendees alike applauded for its excellent networking opportunities and for drawing in large numbers of the general public. The buzz and excitement over the weekend has been fabulous!”
The hope now is that RAREfest will be an annual event: the weekend certainly showed the demand is there.
More by this authorMike Scialom
This website and its associated newspaper are members of the Independent Press Standards Organisation (IPSO)